Catium ConviCap is an inhalation capsule manufactured by Incepta Pharmaceuticals Ltd. in Bangladesh. It contains a combination of Indacaterol Maleate (27.5 µg) and Glycopyrronium Bromide (15.6 µg) per capsule. This medication is primarily used for the long-term maintenance treatment of airflow obstruction in patients with Chronic Obstructive Pulmonary Disease (COPD).